Reversal of a rocuronium-induced grade IV anaphylaxis via early injection of a large dose of sugammadex

Canadian Journal of Anesthesia

Volumn 61, Issue 6, 2014, Pages 558-562

  Conte, Benjamin ^a   Zoric, Lana ^a   Bonada, Gerard ^a   Debaene, Bertrand ^b   Ripart, Jacques ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HISTAMINE; KETAMINE; PROPOFOL; ROCURONIUM; SUFENTANIL; SUGAMMADEX; TRYPTASE; ANDROSTANE DERIVATIVE; EPINEPHRINE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ALLERGY TEST; ANAPHYLAXIS; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CASE REPORT; CHOLECYSTECTOMY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; OBESITY; PRICK TEST; PRIORITY JOURNAL; RASH; YOUNG ADULT; CHEMICALLY INDUCED; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ANAPHYLAXIS; ANDROSTANOLS; CHOLECYSTECTOMY; EPINEPHRINE; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901587627     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-014-0148-3     Document Type: Article

References (14)

1. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM; GERAP. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012; 78: 868-78.
2. Sadleir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013; 110: 981-7.
3. Kawano T, Tamura T, Hamaguchi M, Yatabe T, Yamashita K, Yokoyama M. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth 2012; 24: 62-4.
4. Funnell AE, Griffiths J, Hodzovic I. A further case of rocuronium-induced anaphylaxis treated with sugammadex. Br J Anaesth 2011; 107: 275-6.
5. McDonnell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106: 199-201.
6. Raft J, Leclercq M, Longrois D, Meistelman C. Fast recovery of haemodynamic and ventilatory functions after sugammadex bolus following rocuronium-induced anaphylactic shock refractory to conventional treatment (French). Ann Fr Anesth Reanim 2012; 31: 158-61.
7. Badaoui R, Popov I, Dupont H. A case of rocuronium-induced anaphylactic shock, improved by sugammadex (French). Can J Anesth 2012; 59: 909-10.
8. Pedersen NA, Findsen L, Olsen SK. Should sugammadex be used for the treatment of anaphylaxia induced by rocuronium? American Society of Anesthesia 2010: A539 (abstract). Available from URL: http://www.asaabstracts.com/strands/ asaabstracts/abstractList.htm;jsessionid=51E7E9DD8C30935D82DB080633E7D8D5?year= 2010&index=13 (accessed January 2014).
9. Motamed C, Baguenard P, Bourgain JL. Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex. J Anaesthesiol Clin Pharmacol 2012; 28: 127-8.
10. Mertes PM, Malinovsky JM, Jouffroy L; Working Group of the SFAR and SFA, Aberer W, Terreehorst I, Brockow K, Demoly P; ENDA; EAACI Interest Group on Drug Allergy. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 11: 442-53.
11. Clarke RC, Sadleir PH, Platt PR. The role of sugammadex in the development and modification of allergic response to rocuronium: evidence from cutaneous model. Anaesthesia 2012; 67: 266-73.
12. Leysen J, Bridts CH, De Clerck LS, Ebo DG. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011; 66: 526-7.
13. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217-9.
14. Tokuwaka J, Takahashi S, Tanaka M. Anaphylaxis after sugammadex administration. Can J Anesth 2013; 60: 733-4.